Coleman R., Kennedy I., Humphrey P. (1990) Prostanoids and their receptors. Comprehensive Medicinal Chemistry. Membranes and Receptors , Emmett JC (Ed), Pergamon, Oxford; 3:643-714.
Breyer R., Bagdassarian C., Myers S. (2001) Prostanoid receptors: Subtypes and signaling. Ann. Rev. Pharmacol. Toxicol 41:661-690.
Murat T., Ushikubi F., Matsuoka T. (1997) Altered pain perception and inflammatory response in mice lacking prostacyclin receptor. Nature 388:678-682.
Hoeper M.M., Schwarze M., Ehlerding S. (2000) Long-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogue. N. Engl. J. Med 342:1866-1870.
Tuder R.M., Cool C.D., Geraci M.W. (1999) Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension. Am. J. Respir. Crit. Care Med 159:1925-1932.
Lewis R.A., Soter N.A., Diamond P.T. (1982) Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE. J. Immunol 129:1627-1631.
Urade Y., Hayaishi O. (1999) Prostaglandin D2 and sleep regulation. Biochim. Biophys. Acta , 1436; 606-615.
Sri Kantha S., Matsumura H., Kubo E. (1994) Effects of prostaglandin D2, lipoxins and leukotrienes on sleep and brain temperature of rats. Prostaglandin Leukot. Essent. Fatty Acids 51:87-93.
Gilles H., Leff P., Bolofo M.L. (1989) The classification of prostaglandin DP-receptors in platelets and vasculature using BW A868C, a novel, selective and potent competitive antagonist. Dr J. Pharmacol 96:291-300.
Sugimoto Y., Yamasaki A., Segi E. (1997) Failure of parturition in mice lacking the prostaglandin F receptor. Science 277:681-683.
Lydford S., McKechnie K., Dougall I. (1996) Pharmacological studies on prostanoid receptors in the rabbit isolated saphenous vein: A comparison with the rabbit isolated ear artery. Br. J. Pharmacol 117:13-20.
Coleman R.A., Grix S.P., Head S.A. (1994) A novel inhibitory prostanoid receptor in piglet saphenous vein. Prostaglandins 47:151-168.
Lawrence R.A., Jones R.L. (1992) Investigation of the prostaglandin E (EP-) receptor subtype mediating relaxation of the rabbit jugular vein. Br. J. Pharmacol 105:817-824.
Daniels E., Hinman J., Leach B. (1967) Identification of prostaglandin E2 as the principal vasodepressor lipid of rabbit renal medulla. Nature 215:1298-1299.
Coleman R.A., Smith W.L., Narumiya S. (1994) International Union of Pharmacology classification of prostanoid receptors: Properties, distribution, and structure of the receptors and their subtypes. Pharmacol. Rev 46:205-229.
Kiriyama M., Ushikubi F., Kobayashi T. (1997) Ligand binding specificities of the eight types and subtypes of mouse prostanoid receptors expressed in Chinese hamster ovary cells. Br. J. Pharmacol 122:217-224.
Boie Y., Stocco R., Sawyer N. (1997) Molecular cloning and characterization of the four rat prostaglandin E2 prostanoid receptor subtypes. Eur. J. Pharmacol 340:227-241.
Gardiner P.J. (1986) Characterization of prostanoid relaxant/inhibitory receptors (psi) using a highly selective agonist, TR4979. Br. J. Pharmacol 87:45-56.
Segi E., Sugimoto Y., Yamasaki A. (1998) Patent ductus arteriosus and neonatal death in prostaglandin receptor EP4-deficient mice. Biochem. Biophys. Res. Commun 246:7-12.
Nguyen M., Camenisch T., Snouwaert J. (1997) The prostaglandin receptor EP4 triggers remodelling of the cardiovascular system at birth. Nature 390:78-81.
De Leval X., Delarge J., Somers F. (2000) Recent advances in inducible cyclooxygenase (COX-2) inhibition. Curr. Med. Chem 10:1041-1062.
De Leval X., Julemont F., Delarge J. (2002) Recent advances in the file of COX-2 inhibition. Expert Opin. Ther. Patents 12(7):969-989.
Dogne J.M., De Leval X., Delarge J. (2001) Recent developments of thromboxane modulators. Expert Opin. Ther. Patents 11(11):1663-1675.
